CClinicalTrials.gg
CompletedNCT04988737Updated Nov 25, 2025

Usability of a Perioperative Medication-Related Clinical Decision Support Application

An interventional study of Electronic Clinical Decision Support Application in Perioperative Medication Errors and Perioperative Adverse Medication Events, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-25.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2021, registered Jul 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The goal of this study is to compare the usability of a novel, medication-related clinical decision support (CDS) application to the current standard medication administration and documentation workflow. The study will occur in a simulation setting, using a manikin and test patient data - no actual patients will participate. Forty clinician participants will be randomly assigned to either the CDS group (who will complete simulation tasks using the CDS prototype) or the Control group (who will complete simulation tasks using the standard medication administration workflow).

02

Conditions studied

  • Perioperative Medication Errors
  • Perioperative Adverse Medication Events

Keywords

  • Usability
  • Clinical Decision Support
  • Anesthesiology
  • Medication Safety
03

In context

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Anesthesia Clinicians including attending anesthesiologists, Certified Registered Nurse Anesthetists (CRNAs), and house staff (residents and fellows)

Exclusion criteria

Exclusion Criteria:

  • Study Staff
  • Medical Students
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    CDS Group

    Clinicians complete tasks using the CDS prototype. Briefly, the clinician scans the barcode on the syringe label immediately prior to medication administration. The scan triggers the CDS to display a dosing window with pertinent patient-specific information and/or alert(s) when necessary to prevent a medication error (ME) prior to the medication being administered. Medication data are then sent from the CDS application to the patient's anesthesia record for automatic documentation in real-time, eliminating the need to manually document the medication in the Anesthesia Information Management System (AIMS). When necessary, the CDS application generates alerts to prevent medication errors. Upon receiving an alert, the anesthesia clinician may accept the alert and revise the action that generated the alert, or override the alert and continue with the planned action.

    Other: Electronic Clinical Decision Support Application

  • No intervention
    Control Group

    Clinicians complete tasks using the conventional medication administration and documentation workflow in anesthesia.

Interventions

  • OtherElectronic Clinical Decision Support Application

    Robust, real-time medication-related clinical decision support application for use in the operating room. The application is fully integrated with existing clinical systems. It provides visual alerts for medication errors and adverse medication events at the point-of-care.

06

What researchers measure

Primary outcomes

  1. Total time to complete 7 simulations tasks.

    Total time (in seconds) to complete 7 simulations tasks.

    Time frame: Measured from task start time to task end time, a cumulative average of 15 minutes

Secondary outcomes

  1. Total number of mouse clicks in 7 simulations tasks.

    Total count of mouse clicks during all 7 simulations tasks.

    Time frame: Measured from task start time to task end time, a cumulative average of 15 minutes

  2. Total distance traveled on the screen in pixels for 7 simulation tasks.

    Total distance traveled on the screen in pixels during all 7 simulation tasks.

    Time frame: Measured from task start time to task end time, a cumulative average of 15 minutes

Other outcomes

  1. System Usability Scale (SUS) score.

    SUS is designed and validated only for first-time system users, so it will be completed by the CDS group only. SUS scores range from 0 to 100 (higher score indicates higher usability). The scores are not percentiles, but are interpreted using benchmark comparisons to industry standards.

    Time frame: Measured at the conclusion of study participation, an average of 15 minutes after the participant's start time

  2. Number of usability issues.

    Usability issues are defined as aspects of the system that prevent the user from accomplishing their goals with effectiveness, efficiency and satisfaction. Usability issues will be identified for the CDS group only. Usability issues will be identified by a usability expert.

    Time frame: Identified continuously over the duration of study participation, a cumulative average of 15 mins

  3. Single Ease Question score for each simulation task.

    "Overall, how difficult or easy did you find this task?" Answers will be recorded on a 7-point Likert scale (1= "very difficult"; 7= "very easy").

    Time frame: Measured at the end of each of the 7 tasks (each task requires an average of 3 minutes to complete)

07

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04988737
Lead sponsor
Massachusetts General Hospital
Responsible party
Karen C. Nanji,M.D.,M.P.H. (Principal Investigator, Massachusetts General Hospital) — Principal investigator
First posted
Aug 3, 2021
Start date
Jan 27, 2021
Primary completion
Feb 10, 2021
Completion
Feb 10, 2021
Last update
Nov 25, 2025

Study contacts

Karen C Nanji, MD, MPH
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion